Identification of the second CFTR mutation in patients with congenital bilateral absence of vas deferens undergoing ART protocols.
Congenital bilateral absence of vas deferens (CBAVD) is a manifestation of the mildest form of cystic fibrosis (CF) and is characterized by obstructive azoospermia in otherwise healthy patients. Owing to the availability of assisted reproductive technology, CBAVD patients can father children. These fathers are at risk of transmitting a mutated allele of the CF transmembrane conductance regulator (CFTR) gene, responsible for CF, to their offspring. The identification of mutations in both CFTR alleles in CBAVD patients is a crucial requirement for calculating the risk of producing a child with full-blown CF if the female partner is a healthy CF carrier. However, in the majority of CBAVD patients, conventional mutation screening is not able to detect mutations in both CFTR alleles, and this difficulty hampers the execution of correct genetic counselling. To obtain information about the most represented CFTR mutations in CBAVD patients, we analysed 23 CBAVD patients, 15 of whom had a single CFTR mutation after screening for 36 mutations and the 5T allele. The search for the second CFTR mutation in these cases was performed by using a triplex approach: (i) first, a reverse dot-blot analysis was performed to detect mutations with regional impact; (ii) next, multiple ligation-dependent probe amplification assays were conducted to search for large rearrangements; and (iii) finally, denaturing high-performance liquid chromatography was used to search for point mutations in the entire coding region. Using these approaches, the second CFTR mutation was detected in six patients, which increased the final detection rate to 60.8%.
Giuliani
Rossella
R
Department of Clinical Sciences and Bioimages, 'G. d'Annunzio' University, Chieti-Pescara 66013, Italy.
Antonucci
Ivana
I
Torrente
Isabella
I
Grammatico
Paola
P
Palka
Giandomenico
G
Stuppia
Liborio
L
D000328:Adult; D003550:Cystic Fibrosis / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D005260:Female; D006801:Humans; D007248:Infertility, Male / Q000235:genetics*; D008297:Male; D052801:Male Urogenital Diseases; D015336:Molecular Probe Techniques; D027724:Reproductive Techniques, Assisted; D014564:Urogenital Abnormalities / Q000235:genetics; D014649:Vas Deferens / Q000002:abnormalities*
D019005:Cystic Fibrosis Transmembrane Conductance Regulator